Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

CAS 10316-61-7

2-(Hydroxymethyl)-2-methylcyclohexan-1-one

登记编号:(I)101438-78-a

应用背景(按来源药适应症)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

来源药(使用该中间体的合成路线)

品种梯队到期年
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C · 观察 / 贸易-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

Paclitaxel/Encequidar mesylate优化路线步数:8总收率:/
2-(Hydroxymethyl)-2-methylcyclohexan-1-one→2-[(Ethoxymethoxy)methyl]-2-methylcyclohexan-1-one→2,4,6-Triisopropylbenzenesulfonohydrazide→N'-[2-[(Ethoxymethoxy)methyl]-2-methylcyclohexylidene]-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide→(4S*,5S*)-7-Ethenyl-4-[(6S*)-6-(hydroxymethyl)-6-methylcyclohex-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one→(1S*)-3-Ethenyl-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-ene-1-carbaldehyde→(S*)-[(1S*)-3-Ethenyl-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-en-1-yl][(6R)-6-[(ethoxymethoxy)methyl]-6-methylcyclohex-1-en-1-yl]methanol→(1S*)-3-Ethenyl-1-[(S*)-[(6R*)-6-[(ethoxymethoxy)methyl]-6-methylcyclohex-1-en-1-yl](hydroxy)methyl]-2,2,4-trimethylcyclohex-3-en-1-ol→(4S*,5S*)-7-Ethenyl-4-[(6S*)-6-[(ethoxymethoxy)methyl]-6-methylcyclohex-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one→(1R*)-2-[(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]-1-methylcyclohex-2-ene-1-carbaldehyde→5-(Hex-5-ene-1-sulfonyl)-1-phenyl-1H-tetrazole→(4S*,5S*)-7-Ethenyl-4-[(6S*)-6-[hepta-1,6-dien-1-yl]-6-methylcyclohex-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one

本站可供应的对应中间体

目录暂未收录该靶点的在售中间体 —— 可直接发起询价,需求会进入撮合池。

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。